Molnupiravir (or MONEYpiravir): Merck pill used to combat Covid-19 failed to demonstrate it can lower the risk of hospitalization compared with a placebo among adults at a higher risk from the disease
by Paul Alexander
Merck’s Covid-19 pill was no better than placebo in lowering the risk of hospitalization; Molnupiravir can mutate DNA that can cause Cancer, Infertility, Birth Defects
SOURCE:
https://www.statnews.com/pharmalot/2022/10/07/covid19-merck-molnupiravir-fda-mhra-hospitalization/